Ralph -
I don't know why it has back-tracked from
41 to 36.
On its way *UP* it seemed to hit resistance points
at 30 , 33 , 36 , 40. (Note: I don't know or
understand TA - these points are my gut)
I do not think (Redux) or (Redux and AHP) has
anything to do with the back-tracking.
As far as AHP is concerned, they have anted up
about 16 mil. so, I would think, they are looking
to get a payback ASAP. As you may know, in total, they
will have to ante up about 23 mil.
From an investment point, the big question is, how big
is the market - TRULY - , and will first time users come
back and use it again a second time. We really won't know
this, in my opinion, for another 6 to 9 months.
Lastly, you may be wondering:is there room for anymore
run-up? I am wondering that too.
At 40/shr., we are talking 400 mil in market value
- which seems rich - but I don't know how to value the market
and what the product is really worth.
FYI - If you are interested in learning more about the whole
subject, Eduardo is on the ANIK thread. He is *very* smart and
helpful. He has also pointed out, that ANIK, which basically
sells the same thing as BIOX - looks like a good deal at its
current price. (Note:I am NOT a salesmen - this is an FYI)
Regards,
John McCarthy
|
